Apolipoprotein(a) size and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease
- 30 June 1996
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 123 (1-2) , 181-191
- https://doi.org/10.1016/0021-9150(96)05806-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Lp(a) lipoprotein in cardiovascular diseaseAtherosclerosis, 1994
- Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) miceNature, 1994
- Apolipoproteins and ischaemic heart disease: implications for screeningThe Lancet, 1994
- A prospective study of lipoprotein(a) and the risk of myocardial infarctionJAMA, 1993
- Lipoprotein (a)Current Opinion in Lipidology, 1993
- Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participantsAtherosclerosis, 1991
- Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.BMJ, 1990
- Lipoprotein (a). Heterogeneity and biological relevance.Journal of Clinical Investigation, 1990
- The Mysteries Of Lipoprotein(a)Science, 1989
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987